XML 33 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net loss $ (22,672,532) $ (20,384,715) $ (19,922,515)
Adjustments to reconcile net loss to net cash used in operating activities:      
Gain on sale of fixed assets     (8,811)
Depreciation and amortization 969,500 562,803 552,860
Issuance of common stock award   172,000  
Write off of unamortized financing costs 62,391    
Noncash compensation 1,487,550 3,183,131 727,156
Changes in operating assets and liabilities:      
Increase in accounts receivable (179,956)    
Increase in inventory (675,602)    
Decrease (Increase) in prepaid expenses and other current assets 95,926 (537,878) 141,290
(Decrease) increase in accounts payable and accrued expenses 1,389,939 (239,776) (121,321)
(Decrease) increase in other current liabilities 9,818 1,455 (3,747)
Increase in other assets (19,643) (248,793) (289,705)
Increase in deferred rent 5,556 33,912 104,304
Increase in deferred revenue 303,377    
Net cash used in operating activities (19,223,676) (17,457,861) (18,820,489)
Cash flows from investing activities:      
Purchases of property and equipment (6,158,326) (104,092) (1,044,079)
Proceeds from disposal of fixed assets     10,284
Net cash used in investing activities (6,158,326) (104,092) (1,033,795)
Cash flows from financing activities:      
Net proceeds from private placements/public offerings 5,201,896 15,024,662 15,233,671
Net proceeds from Committed Equity Financing Facility     3,743,283
Proceeds from exercise of stock options 44,759 13,350 33,088
Proceeds from exercise of stock warrants     1,691,634
Net cash provided by financing activities 5,246,655 15,038,012 20,701,676
Net increase (decrease) in cash and cash equivalents (20,135,347) (2,523,941) 847,392
Cash and cash equivalents at beginning of year 27,996,871 30,520,812 29,673,420
Cash and cash equivalents at end of year 7,861,524 27,996,871 30,520,812
Supplemental Schedule of Noncash Investing and Financing Activities:      
Amortization of deferred financing costs 41,179   23,179
Reclassification of MelaFind components from other assets to property and equipment $ 522,014